[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"osteopenia-of-prematurity\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:osteopenia-of-prematurity":50},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100531384",false,"NCT06199102","The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.","The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants. A Randomized Controlled Study.","HIDVID","Inclusion Criteria:\n\n* preterm infants with a gestational age of 24+0\u002F7 to 32+6\u002F7 born at our clinic\n* preterm infants with a gestational age of 24+0\u002F7 to 32+6\u002F7 outborn and admitted to our intensive care unit within 48h after delivery\n* written informed consent form caregivers for the mother and the child to participate in the study\n\nExclusion Criteria:\n\n* infants born at \\>32 weeks of gestation\n* infants with major congenital abnormalities or other severe congenital malformations\n* infants with genetic disorders (diagnosed before and after birth) deemed incompatible with survival\n* infants with diagnosed cholestasis\n* the absence of written informed consent and challenges in communication with caregivers","ALL","1 Day","2 Days",{"count":20,"type":21},130,"ESTIMATED","INTERVENTIONAL",[24],"NA","The aim of this study will be to assess the effectiveness of monitored vit D supplementation in a population of preterm infants and to identify whether the proper vit D supplementation in preterm infants can reduce the incidence of neonatal sepsis and incidence of metabolic bone disease.",[27,28,29,30,31],"Vitamin D Deficiency","Osteopenia of Prematurity","Nephrolithiasis","Metabolic Bone Disease","Late-Onset Neonatal Sepsis",[33,34,35,36,37],"vitamin D","preterm infants","osteopenia of prematurity","late-onset sepsis","metabolic bone disease","NOT_YET_RECRUITING","2024-01-09",{"date":41,"type":42},"2024-01-10","ACTUAL",{"date":44,"type":21},"2024-09-01",{"date":46,"type":21},"2027-12-31",{"name":48,"class":49},"Princess Anna Mazowiecka Hospital, Warsaw, Poland","OTHER",""]